Academic Journal
Q1Chinese Journal of Cancer Research
About Chinese Journal of Cancer Research
Chinese Journal of Cancer Research is a scholarly journal published by Chinese Journal of Cancer Research Co., Ltd. and Peking University Cancer Hospital and Institute. SCImago 2025 lists it in Q1, with an SJR of 1.406 and H-index of 51.
Coverage: 1988-1996, 1998-2017, 2020-2025. Research categories: Oncology (Q1); Cancer Research (Q2).
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Scope information will be added after verification.
Recent Research Articles
Latest publications matched automatically by ISSN.
Overcoming barriers to bladder preservation: Emerging intravesical therapies for high-risk non-muscle invasive bladder cancer
Pan Shenhao, Xu Wentong, Xiang Yong, Huang Ming et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.04.04Circulating tumor cells with chromosome 8 aneuploidy are a diagnostic and prognostic monitoring biomarker for ovarian cancer
Yang Shimin, Li Buyun, Cheng Hongyan, Ye Xue et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.01.05Rethinking false-negative rate of sentinel node navigation surgery after non-curative endoscopic submucosal dissection: Insights from SENORITA 2 trial
Wang Zimeng, Zheng Zhi, Yin Jie, Chen Guangyong et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.03.13Development of an interpretable machine learning model for lymphovascular space invasion prediction in patients with endometrioid endometrial carcinoma: A prospective study
Wu Meixuan, Zhou Ling, Yang Xiao, Yang Sihui et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.02.10Chemotherapy-free regimen: Real-world efficacy and safety of anlotinib plus PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer
Chen Haiyang, Yang Guanghua, Wang Tao, Chen Gongbin et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.01.03Refined immune-based molecular subtypes of gastric cancer: Integrating mismatch repair status and tumor microenvironment for enhanced immunotherapy prediction
Shen Ke, Zhang Yanqiang, Wang Zhiqin, Xu Ruixing et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.02.09Preface to Special Issue: AI-driven comprehensive cancer therapy: Strategy construction, basic and translational research
Zhu Lei
2026 · DOI: 10.21147/j.issn.1000-9604.2026.02.01Evaluating diagnostic efficacy of multigene testing in non-diagnostic thyroid nodules by fine-needle aspiration cytology: A prospective cohort study
Zhang Guozhi, Ren Lin, Xiao Jia, Bao Yangqiu et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.01.02Gastric cancer surgery in the era of neoadjuvant immunotherapy
Ji Jiafu, Ji Ke, Su Hao
2026 · DOI: 10.21147/j.issn.1000-9604.2026.03.05Is sentinel node navigation surgery feasible after non-curative endoscopic resection in patients with early gastric cancer?
Wool Eom Bang, Jun Ahn Woo, Man Yoon Hong, Woo Kim Young et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.03.12Development and validation of a neutrophil percentage to albumin ratio-based nomogram for predicting survival in patients with locally advanced gastric cancer
Deng Shunyu, Liu Maoxing, Tan Fei, Xing Jiadi et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.03.16Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathway
Wang Zhipeng, Wang Jie, Chen Shuang, Wu Ruicheng et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.01.06Radiation oncology at a new frontier: Hotspots, challenges, and emerging advances
Wei Baochao, Zhang Zengfu, Chen Dawei, Yu Jinming et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.04.02Breakthroughs in malignancy therapy: New advances and emerging trends in renal cell carcinoma
Yan Xieqiao, Wu Xiaowen, Sheng Xinan
2026 · DOI: 10.21147/j.issn.1000-9604.2026.03.07Managing evolution of metastatic prostate cancer: From hormone-sensitive to castration-resistant disease
Wu Shengpan, Zhang Xu
2026 · DOI: 10.21147/j.issn.1000-9604.2026.03.04Circulating tumor DNA-based minimal residual disease-guided adjuvant therapy in solid tumors: Current evidence, clinical trial frameworks, and future directions
Ma Mingchi, Xia Beian, Xu Qian, Chu Jiahui et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.04.06Immune decoding from a multi-omics perspective: Redefining pancreatic cancer tumor microenvironment
Zhang Enkui, Yang Yinmo
2026 · DOI: 10.21147/j.issn.1000-9604.2026.03.08Turmoil and breakthroughs: Highlights and growing pains in breast cancer therapy 2025−2026
Jiang Mingxia, Xu Binghe
2026 · DOI: 10.21147/j.issn.1000-9604.2026.03.03Preface to Special Issue: Breakthroughs in malignancy therapy: New advances and emerging trends—Awakening immune system: The new era of radioimmunotherapy
Zhang Zengfu, Yu Jinming
2026 · DOI: 10.21147/j.issn.1000-9604.2026.03.01A CT-based deep learning model with biological interpretation for predicting early recurrence after neoadjuvant therapy in gastric cancer
Weng Caiming, Zhong Qing, Chen Lihong, Sun Yuqin et al.
2026 · DOI: 10.21147/j.issn.1000-9604.2026.04.09Reviews
Community Reviews
Version History
September 25, 2026 at 7:31 am
September 25, 2026